InsiderTrades.com logo

PHGE Insider Trading

Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

BiomX Insider Trading History Chart

This chart shows the insider buying and selling history at BiomX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiomX Share Price & Price History

Current Price: $1.91
Price Change: ▲ Price Increase of +1.166 (157.78%)
As of 12/18/2025 04:58 PM ET

This chart shows the closing price history over time for PHGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BiomX Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2024Israel Biofund Gp Limi OrbimedMajor ShareholderSell128$72.20$9,241.6072,492View SEC Filing Icon  
5/22/2023Assaf OronInsiderBuy16$51.30$820.8057View SEC Filing Icon  
2/27/2023Israel Biofund Gp Limi OrbimedMajor ShareholderBuy1,831$45.60$83,493.6016,639View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BiomX (NYSEMKT:PHGE)

40.57% of BiomX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHGE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BiomX Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Alyeska Investment Group L.P.1,590,738$0.84M0.0%N/A5.990%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC161,781$85K0.0%N/A0.609%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC104,463$55K0.0%-56.0%0.393%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC77,656$41K0.0%-74.1%0.292%Search for SEC Filing on Google Icon
8/12/2025Warberg Asset Management LLC80,000$36K0.0%-19.7%0.306%Search for SEC Filing on Google Icon
5/16/2025Allostery Investments LP940,629$0.52M0.8%+46.1%3.763%Search for SEC Filing on Google Icon
5/16/2025Alyeska Investment Group L.P.1,590,738$0.88M0.0%+83.8%6.364%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC299,598$0.17M0.0%N/A1.199%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC2,493,309$1.39M0.1%+44.1%9.975%Search for SEC Filing on Google Icon
5/9/2025Warberg Asset Management LLC99,616$55K0.0%N/A0.399%Search for SEC Filing on Google Icon
5/6/2025AIGH Capital Management LLC1,566,944$0.87M0.4%+81.1%6.269%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.865,400$0.63M0.0%N/A4.761%Search for SEC Filing on Google Icon
2/17/2025Allostery Investments LP643,833$0.47M0.5%N/A3.542%Search for SEC Filing on Google Icon
2/14/2025Heights Capital Management Inc.258,492$0.19M0.1%-56.1%1.422%Search for SEC Filing on Google Icon
2/14/2025Johnson & Johnson96,866$71K0.0%-49.6%0.533%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.429,990$0.31M0.0%N/A2.366%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC25,000$26K0.0%-90.0%0.138%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC25,000$26K0.0%-90.0%0.140%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC893,000$0.91M0.1%N/A4.990%Search for SEC Filing on Google Icon
11/14/2024Johnson & Johnson192,321$0.20M0.0%-90.0%1.075%Search for SEC Filing on Google Icon
11/7/20248VC GP I LLC108,621$0.11M0.2%-90.0%0.607%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590%Search for SEC Filing on Google Icon
5/10/2024Johnson & Johnson1,923,201$0.87M0.0%-9.9%3.483%Search for SEC Filing on Google Icon
11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP320,655$0.62M0.0%+200.5%1.077%Search for SEC Filing on Google Icon
2/7/2022Royce & Associates LP106,696$0.17M0.0%-52.7%0.373%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson2,133,402$6.53M0.6%N/A7.568%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BiomX logo
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More on BiomX

Today's Range

Now: $1.91
Low: $0.72
High: $0.78

50 Day Range

MA: $6.91
Low: $1.57
High: $11.97

52 Week Range

Now: $1.91
Low: $0.34
High: $2.40

Volume

53,300 shs

Average Volume

347,190 shs

Market Capitalization

$2.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.56

Who are the company insiders with the largest holdings of BiomX?

BiomX's top insider shareholders include:
  1. Israel Biofund Gp Limi Orbimed (Major Shareholder)
Learn More about top insider investors at BiomX.

Who are the major institutional investors of BiomX?

BiomX's top institutional investors include:
  1. Alyeska Investment Group L.P. — 5.99%
  2. Citadel Advisors LLC — 0.61%
  3. Boothbay Fund Management LLC — 0.39%
  4. ADAR1 Capital Management LLC — 0.29%
Learn More about top institutional investors of BiomX stock.

Which institutional investors are selling BiomX stock?

During the last quarter, PHGE stock was sold by these institutional investors:
  1. ADAR1 Capital Management LLC
  2. Boothbay Fund Management LLC

Which institutional investors are buying BiomX stock?

In the previous quarter, PHGE stock was purchased by institutional investors including:
  1. Alyeska Investment Group L.P.
  2. Citadel Advisors LLC